Sirtuins in Atherosclerosis: Guardians of Healthspan and Therapeutic Targets

Overview

Journal Nat Rev Cardiol

Specialty Cardiology & Vascular Diseases

Date 2022 Mar 31

PMID 35354967

Authors

Mandy O J Grootaert

Martin R Bennett

Affiliations

Soon will be listed here.

Abstract

Sirtuins are NAD-dependent deacetylase and deacylase enzymes that control important cellular processes, including DNA damage repair, cellular metabolism, mitochondrial function and inflammation. Consequently, mammalian sirtuins are regarded as crucial regulators of cellular function and organism healthspan. Sirtuin activity and NAD levels decrease with age in many tissues, and reduced sirtuin expression is associated with several cardiovascular diseases. By contrast, increased sirtuin expression and activity slows disease progression and improves cardiovascular function in preclinical models and delays various features of cellular ageing. The potential cardiometabolic benefits of sirtuins have resulted in clinical trials with sirtuin-modulating agents; although expectations are high, these drugs have not yet been proven to improve healthspan. In this Review, we examine the role of sirtuins in atherosclerosis, summarize advances in the development of compounds that activate or inhibit sirtuin activity and critically evaluate the therapeutic potential of these agents.

Citing Articles

Single-Cell Multimodal Profiling Reveals a Novel CD26 Fibroblast Subpopulation in Atherosclerosis.

Bashore A, Coronel J, Xue C, Zhu L, Reilly M bioRxiv. 2025; .

PMID: 39975362 PMC: 11838260. DOI: 10.1101/2025.01.27.635067.

Sirtuins in kidney homeostasis and disease: where are we now?.

Fan Z, Wei X, Zhu X, Du Y Front Endocrinol (Lausanne). 2025; 15:1524674.

PMID: 39911234 PMC: 11794115. DOI: 10.3389/fendo.2024.1524674.

Evaluation of sirtuin 1 as a predictor of cardiovascular outcomes in diabetic patients with limb-threatening ischemia.

Biscetti F, Rando M, Nicolazzi M, Rossini E, Santoro M, Angelini F Sci Rep. 2024; 14(1):26940.

PMID: 39506067 PMC: 11542011. DOI: 10.1038/s41598-024-78576-z.

Cell senescence in cardiometabolic diseases.

Grootaert M NPJ Aging. 2024; 10(1):46.

PMID: 39433786 PMC: 11493982. DOI: 10.1038/s41514-024-00170-4.

The Role of Sirtuin-1 Isoforms in Regulating Mitochondrial Function.

Patyal P, Ameer F, Verma A, Zhang X, Azhar G, Shrivastava J Curr Issues Mol Biol. 2024; 46(8):8835-8851.

PMID: 39194739 PMC: 11352618. DOI: 10.3390/cimb46080522.

References

Imai S, ARMSTRONG C, Kaeberlein M, Guarente L . Transcriptional silencing and longevity protein Sir2 is an NAD-dependent histone deacetylase. Nature. 2000; 403(6771):795-800. DOI: 10.1038/35001622. View

Haigis M, Sinclair D . Mammalian sirtuins: biological insights and disease relevance. Annu Rev Pathol. 2010; 5:253-95. PMC: 2866163. DOI: 10.1146/annurev.pathol.4.110807.092250. View

Imai S, Guarente L . NAD+ and sirtuins in aging and disease. Trends Cell Biol. 2014; 24(8):464-71. PMC: 4112140. DOI: 10.1016/j.tcb.2014.04.002. View

Imai S, Guarente L . It takes two to tango: NAD and sirtuins in aging/longevity control. NPJ Aging Mech Dis. 2017; 2:16017. PMC: 5514996. DOI: 10.1038/npjamd.2016.17. View

Revollo J, Grimm A, Imai S . The NAD biosynthesis pathway mediated by nicotinamide phosphoribosyltransferase regulates Sir2 activity in mammalian cells. J Biol Chem. 2004; 279(49):50754-63. DOI: 10.1074/jbc.M408388200. View

Guarente L . Calorie restriction and sirtuins revisited. Genes Dev. 2013; 27(19):2072-85. PMC: 3850092. DOI: 10.1101/gad.227439.113. View

Kane A, Sinclair D . Sirtuins and NAD in the Development and Treatment of Metabolic and Cardiovascular Diseases. Circ Res. 2018; 123(7):868-885. PMC: 6206880. DOI: 10.1161/CIRCRESAHA.118.312498. View

You W, Rotili D, Li T, Kambach C, Meleshin M, Schutkowski M . Structural Basis of Sirtuin 6 Activation by Synthetic Small Molecules. Angew Chem Int Ed Engl. 2016; 56(4):1007-1011. DOI: 10.1002/anie.201610082. View

You W, Zheng W, Weiss S, Chua K, Steegborn C . Structural basis for the activation and inhibition of Sirtuin 6 by quercetin and its derivatives. Sci Rep. 2019; 9(1):19176. PMC: 6914789. DOI: 10.1038/s41598-019-55654-1. View

10.

Tenhunen J, Kucera T, Huovinen M, Kublbeck J, Bisenieks E, Vigante B . Screening of SIRT6 inhibitors and activators: A novel activator has an impact on breast cancer cells. Biomed Pharmacother. 2021; 138:111452. DOI: 10.1016/j.biopha.2021.111452. View

11.

Huang Z, Zhao J, Deng W, Chen Y, Shang J, Song K . Identification of a cellularly active SIRT6 allosteric activator. Nat Chem Biol. 2018; 14(12):1118-1126. DOI: 10.1038/s41589-018-0150-0. View

12.

Guo J, Wang Z, Wu J, Liu M, Li M, Sun Y . Endothelial SIRT6 Is Vital to Prevent Hypertension and Associated Cardiorenal Injury Through Targeting Nkx3.2-GATA5 Signaling. Circ Res. 2019; 124(10):1448-1461. DOI: 10.1161/CIRCRESAHA.118.314032. View

13.

Grootaert M, Finigan A, Figg N, Uryga A, Bennett M . SIRT6 Protects Smooth Muscle Cells From Senescence and Reduces Atherosclerosis. Circ Res. 2020; 128(4):474-491. PMC: 7899748. DOI: 10.1161/CIRCRESAHA.120.318353. View

14.

Arsiwala T, Pahla J, Van Tits L, Bisceglie L, Gaul D, Costantino S . Sirt6 deletion in bone marrow-derived cells increases atherosclerosis - Central role of macrophage scavenger receptor 1. J Mol Cell Cardiol. 2020; 139:24-32. DOI: 10.1016/j.yjmcc.2020.01.002. View

15.

Tanno M, Sakamoto J, Miura T, Shimamoto K, Horio Y . Nucleocytoplasmic shuttling of the NAD+-dependent histone deacetylase SIRT1. J Biol Chem. 2007; 282(9):6823-32. DOI: 10.1074/jbc.M609554200. View

16.

Wang R, Sengupta K, Li C, Kim H, Cao L, Xiao C . Impaired DNA damage response, genome instability, and tumorigenesis in SIRT1 mutant mice. Cancer Cell. 2008; 14(4):312-23. PMC: 2643030. DOI: 10.1016/j.ccr.2008.09.001. View

17.

Martinez-Pastor B, Mostoslavsky R . Sirtuins, metabolism, and cancer. Front Pharmacol. 2012; 3:22. PMC: 3282920. DOI: 10.3389/fphar.2012.00022. View

18.

Brunet A, Sweeney L, Sturgill J, Chua K, Greer P, Lin Y . Stress-dependent regulation of FOXO transcription factors by the SIRT1 deacetylase. Science. 2004; 303(5666):2011-5. DOI: 10.1126/science.1094637. View

19.

Houtkooper R, Pirinen E, Auwerx J . Sirtuins as regulators of metabolism and healthspan. Nat Rev Mol Cell Biol. 2012; 13(4):225-238. PMC: 4872805. DOI: 10.1038/nrm3293. View

20.

Yeung F, Hoberg J, Ramsey C, Keller M, Jones D, Frye R . Modulation of NF-kappaB-dependent transcription and cell survival by the SIRT1 deacetylase. EMBO J. 2004; 23(12):2369-80. PMC: 423286. DOI: 10.1038/sj.emboj.7600244. View